Stelios Papadopoulos stock trades
Director at Exelixis and Ovid Therapeutics
1 open-market trade reported in the last 12 months: 1 sale for $4.4M. The newest was filed Nov 13, 2025.
The 2 companies Stelios Papadopoulos files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 1 | ||
| 0 |
Stelios Papadopoulos's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site.
| Stock | Trade | Traded |
|---|---|---|
| Sell$4.4M | Nov 12, 2025SEC filing |
2 other filings on record (stock awards). Pro members see every trade, the shares Stelios Papadopoulos held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Michael Morrissey
- Christopher J. Senner
- Patrick J. Haley
- Dana Aftab
- Brenda Hefti
- Mary C. Beckerle
- Julie Smith
- Bob Oliver
- Jack L. Wyszomierski
- Sue Gail Eckhardt
- David Edward Johnson
- George Poste
- Maria C. Freire
- Tomas J. Heyman
- Margaret A. Alexander
- Jeremy M. Levin
- Charles Ross Carter
- Jeffrey A. Rona
- Kevin Joseph Fitzgerald
- Bart Friedman